FDA Warns About Fungal Meningitis In Transplant Patient Who Received NECC Cardioplegia Solution

Update (October 16): On Tuesday the FDA revised its initial report and said that only one transplant patient who had received the NECC cardioplegia solution had developed fungal meningitis.  The FDA said on Monday that it had identified two transplant patients with Aspergillus fumigatus infection who received cardioplegia solution during surgery. The solution was manufactured by the…

Click here to continue reading…